The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Bayer Global Investments B.v. since year 2005.
The trader's CIK number is 1685417.
At the time of this reporting, Bayer Global Investments B.v. is the 10% Owner of Crispr Therapeutics Ag .
(stock ticker symbol CRSP).
See this page for all insider trading activities at Crispr Therapeutics Ag .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-01-05||CRSP||Crispr Therapeutics Ag||Buy||527,472||22.75||11,999,988|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bayer Global Investments B.v. (10% Owner of Crispr Therapeutics Ag at the time of this reporting) see the Securities and Exchange Commission (SEC) website.